Punjab Chemicals And Crop Prot Share Price
Sector: Chemical Manufacturing
1132.55 -18.25 (-1.59%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1107.55
Today’s High
1157.55
52 Week Low
669.55
52 Week High
1575.00
1112.20 -36.60 (-3.19%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1099.50
Today’s High
1168.00
52 Week Low
662.00
52 Week High
1575.00
Key Metrics
- Market Cap (In Cr) 1387.21
- Beta 1.29
- Div. Yield (%) 0.26
- P/B 3.86
- TTM P/E 29.19
- Peg Ratio -1.61
- Sector P/E 17.01
- D/E 0
- Open Price 1149.55
- Prev Close 1150.8
Punjab Chemicals And Crop Prot Analysis
Price Analysis
-
1 Week2.02%
-
3 Months64.4%
-
6 Month16.97%
-
YTD8.84%
-
1 Year11.72%
Risk Meter
- 53% Low risk
- 53% Moderate risk
- 53% Balanced Risk
- 53% High risk
- 53% Extreme risk
Punjab Chemicals And Crop Prot News
Punjab Chemical hit 52-week-low after reporting 83% fall in Q4 net profit, revenue slips 24%
1 min read . 04 May 2023Punjab Chemicals And Crop Prot Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 900.52
- Selling/ General/ Admin Expenses Total
- 95.09
- Depreciation/ Amortization
- 25.04
- Other Operating Expenses Total
- 168.51
- Total Operating Expense
- 830.55
- Operating Income
- 69.97
- Net Income Before Taxes
- 53.57
- Net Income
- 38.93
- Diluted Normalized EPS
- 34.23
- Period
- 2025
- Total Assets
- 800.6
- Total Liabilities
- 435.89
- Total Equity
- 364.71
- Tangible Book Valueper Share Common Eq
- 292.88
- Period
- 2025
- Cashfrom Operating Activities
- 25.22
- Cashfrom Investing Activities
- -30.26
- Cashfrom Financing Activities
- 12.05
- Net Changein Cash
- 6.55
- Period
- 2024
- Total Revenue
- 934.23
- Selling/ General/ Admin Expenses Total
- 165.52
- Depreciation/ Amortization
- 22.16
- Other Operating Expenses Total
- 0.18
- Total Operating Expense
- 842.29
- Operating Income
- 91.94
- Net Income Before Taxes
- 73.08
- Net Income
- 53.58
- Diluted Normalized EPS
- 43.65
- Period
- 2024
- Total Assets
- 639.79
- Total Liabilities
- 309.63
- Total Equity
- 330.16
- Tangible Book Valueper Share Common Eq
- 265.74
- Period
- 2024
- Cashfrom Operating Activities
- 29.89
- Cashfrom Investing Activities
- -35.85
- Cashfrom Financing Activities
- 3.72
- Net Changein Cash
- -2.31
- Period
- 2023
- Total Revenue
- 1006.21
- Selling/ General/ Admin Expenses Total
- 152.32
- Depreciation/ Amortization
- 19.01
- Other Operating Expenses Total
- 7.73
- Total Operating Expense
- 901.77
- Operating Income
- 104.44
- Net Income Before Taxes
- 88.88
- Net Income
- 61.1
- Diluted Normalized EPS
- 50.18
- Period
- 2023
- Total Assets
- 616
- Total Liabilities
- 335.38
- Total Equity
- 280.62
- Tangible Book Valueper Share Common Eq
- 227.43
- Period
- 2023
- Cashfrom Operating Activities
- 58.21
- Cashfrom Investing Activities
- -36.48
- Cashfrom Financing Activities
- -19.91
- Net Changein Cash
- 0.32
- Period
- 2022
- Total Revenue
- 933.46
- Selling/ General/ Admin Expenses Total
- 136.76
- Depreciation/ Amortization
- 16.67
- Other Operating Expenses Total
- 13.55
- Total Operating Expense
- 809.83
- Operating Income
- 123.63
- Net Income Before Taxes
- 111.61
- Net Income
- 83.46
- Diluted Normalized EPS
- 68.06
- Period
- 2022
- Total Assets
- 557.26
- Total Liabilities
- 331.64
- Total Equity
- 225.62
- Tangible Book Valueper Share Common Eq
- 182.88
- Period
- 2022
- Cashfrom Operating Activities
- 34.31
- Cashfrom Investing Activities
- -27.39
- Cashfrom Financing Activities
- -10.61
- Net Changein Cash
- -3.14
- Period
- 2021
- Total Revenue
- 678.18
- Selling/ General/ Admin Expenses Total
- 110.36
- Depreciation/ Amortization
- 14.86
- Other Operating Expenses Total
- 12.8
- Total Operating Expense
- 595.26
- Operating Income
- 82.92
- Net Income Before Taxes
- 69.01
- Net Income
- 49.08
- Diluted Normalized EPS
- 39.96
- Period
- 2021
- Total Assets
- 451
- Total Liabilities
- 306.47
- Total Equity
- 144.53
- Tangible Book Valueper Share Common Eq
- 116.35
- Period
- 2021
- Cashfrom Operating Activities
- 44.53
- Cashfrom Investing Activities
- -8.11
- Cashfrom Financing Activities
- -25.56
- Net Changein Cash
- 9.83
- Period
- 2020
- Total Revenue
- 549.56
- Selling/ General/ Admin Expenses Total
- 119.32
- Depreciation/ Amortization
- 14.62
- Other Operating Expenses Total
- 7.75
- Total Operating Expense
- 511.2
- Operating Income
- 38.36
- Net Income Before Taxes
- 22.08
- Net Income
- 10.75
- Diluted Normalized EPS
- 8.74
- Period
- 2020
- Total Assets
- 393.93
- Total Liabilities
- 296.18
- Total Equity
- 97.75
- Tangible Book Valueper Share Common Eq
- 77.29
- Period
- 2020
- Cashfrom Operating Activities
- 34.47
- Cashfrom Investing Activities
- -13.52
- Cashfrom Financing Activities
- -18.74
- Net Changein Cash
- 0.83
- Period
- 2025-03-31
- Total Revenue
- 202.28
- Selling/ General/ Admin Expenses Total
- 23.38
- Depreciation/ Amortization
- 6.53
- Other Operating Expenses Total
- 39.08
- Total Operating Expense
- 187.48
- Operating Income
- 14.8
- Net Income Before Taxes
- 10.4
- Net Income
- 7.05
- Diluted Normalized EPS
- 8.06
- Period
- 2025-03-31
- Total Assets
- 800.6
- Total Liabilities
- 435.89
- Total Equity
- 364.71
- Tangible Book Valueper Share Common Eq
- 292.88
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 25.22
- Cashfrom Investing Activities
- -30.26
- Cashfrom Financing Activities
- 12.05
- Net Changein Cash
- 6.55
- Period
- 2024-12-31
- Total Revenue
- 213.89
- Selling/ General/ Admin Expenses Total
- 23.13
- Depreciation/ Amortization
- 6.51
- Other Operating Expenses Total
- 43.27
- Total Operating Expense
- 201.14
- Operating Income
- 12.75
- Net Income Before Taxes
- 8.47
- Net Income
- 6.07
- Diluted Normalized EPS
- 4.95
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 242.13
- Selling/ General/ Admin Expenses Total
- 24.05
- Depreciation/ Amortization
- 6.14
- Other Operating Expenses Total
- 45.42
- Total Operating Expense
- 222.67
- Operating Income
- 19.46
- Net Income Before Taxes
- 16.57
- Net Income
- 12.37
- Diluted Normalized EPS
- 10.09
- Period
- 2024-09-30
- Total Assets
- 695.1
- Total Liabilities
- 343.41
- Total Equity
- 351.69
- Tangible Book Valueper Share Common Eq
- 283.56
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 34.53
- Cashfrom Investing Activities
- -17.63
- Cashfrom Financing Activities
- -13.55
- Net Changein Cash
- 2.9
- Period
- 2024-06-30
- Total Revenue
- 242.22
- Selling/ General/ Admin Expenses Total
- 24.53
- Depreciation/ Amortization
- 5.86
- Other Operating Expenses Total
- 41.57
- Total Operating Expense
- 220.09
- Operating Income
- 22.13
- Net Income Before Taxes
- 18.13
- Net Income
- 13.44
- Diluted Normalized EPS
- 10.96
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 196.53
- Selling/ General/ Admin Expenses Total
- 23.54
- Depreciation/ Amortization
- 6.03
- Other Operating Expenses Total
- 38.17
- Total Operating Expense
- 189.1
- Operating Income
- 7.43
- Net Income Before Taxes
- 3.54
- Net Income
- 2.41
- Diluted Normalized EPS
- 1.93
- Period
- 2024-03-31
- Total Assets
- 639.79
- Total Liabilities
- 309.63
- Total Equity
- 330.16
- Tangible Book Valueper Share Common Eq
- 265.74
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 29.89
- Cashfrom Investing Activities
- -35.85
- Cashfrom Financing Activities
- 3.72
- Net Changein Cash
- -2.31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Punjab Chemicals And Crop Prot Technical
Moving Average
SMA
- 5 Day1122.05
- 10 Day1088.92
- 20 Day1075.33
- 50 Day959.23
- 100 Day931.28
- 300 Day1049.28
Punjab Chemicals And Crop Prot Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- 3b Blackbio Dx
- 1697.2
- 3.55
- 0.21
- 2350
- 765
- 1460.73
- Astec Lifesciences
- 698
- -13.3
- -1.87
- 1487.65
- 635.95
- 1368.22
- Punjab Chemicals And Crop Prot
- 1132.55
- -18.25
- -1.59
- 1575
- 669.55
- 1387.21
- Paushak
- 4638.45
- 38.5
- 0.84
- 6385
- 3746
- 1429.62
- Heubach Colorants India
- 588.05
- 1.85
- 0.32
- 733.25
- 355.15
- 1361.49
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- 3b Blackbio Dx
- 45.37
- 6.54
- 33.47
- 44.85
- Astec Lifesciences
- -
- 6.1
- -0.07
- -0.04
- Punjab Chemicals And Crop Prot
- 34.05
- 3.92
- 23.61
- 6.43
- Paushak
- 28.86
- 3.06
- 13.8
- 25.27
- Heubach Colorants India
- 33.16
- 2.88
- 13.92
- 8.77
Punjab Chemicals And Crop Prot Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 30-Apr-25
- Audited Results & Final Dividend
- 28-Jan-25
- Quarterly Results
- 28-Oct-24
- Quarterly Results
- 01-Aug-24
- Quarterly Results
- 06-May-24
- Audited Results & Final Dividend
- 06-Feb-24
- Quarterly Results
- 26-Oct-23
- Quarterly Results
- 03-Aug-23
- Quarterly Results
- 04-May-23
- Audited Results & Final Dividend
- 24-Jan-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 08-Mar-25
- 04-Feb-25
- POM
- 02-Aug-24
- 12-Jul-24
- AGM
- 28-Sept-23
- 24-Aug-23
- POM
- 04-Aug-23
- 14-Jul-23
- AGM
- 12-Aug-21
- 27-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 30-Apr-25
- -
- -
- 3
- 06-May-24
- -
- 25-Jul-24
- 3
- 04-May-23
- -
- 27-Jul-23
- 3
- 05-May-22
- -
- 01-Aug-22
- 3
- 27-May-21
- -
- 03-Aug-21
- 2


